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a  b  s  t  r  a  c  t
This is a case report of juvenile idiopathic arthritis in two pairs of brothers followed in
the Department of Pediatric Rheumatology, Universidade Federal da Bahia. Genetic involve-
ment in juvenile idiopathic arthritis pathogenesis is clear and the risk of recurrence among
siblings supports this contribution. An important landmark of this discovery involves the
acknowledgment of major histocompatibility complex polymorphism contribution to juve-
nile idiopathic arthritis development susceptibility. Despite many  advances, the numerous
available studies cannot explain several implicit mechanisms in juvenile idiopathic arthritis
pathogenesis yet.
© 2014 Elsevier Editora Ltda. All rights reserved.





r  e  s  u  m  o
Relato de casos de ocorrência de Artrite Idiopática Juvenil (AIJ) em dois pares de irmãos
acompanhados no servic¸o de reumatologia pediátrica da Universidade Federal da Bahia. O
envolvimento genético na patogênese da AIJ está claro e o risco de recorrência entre irmãos
corrobora esta contribuic¸ão. Um importante marco dessa descoberta envolve a conﬁrmac¸ão
da contribuic¸ão dos polimorﬁsmos do complexo principal de histocompatibilidade (MHC)na  susceptibilidade ao desenvolvimento da AIJ. Apesar de muitos progressos, os inúmeros
estudos existentes ainda não são capazes de explicar diversos mecanismos implícitos na
patogênese da AIJ.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.∗ Corresponding author.
E-mail: trobazzi@gmail.com (T.C.M.V. Robazzi).
ttp://dx.doi.org/10.1016/j.rbre.2013.05.005
255-5021/© 2014 Elsevier Editora Ltda. All rights reserved.
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Fig. 1 – Siblings with polyarticular JIA; case report 1.76  r e v b r a s r e u m a
Introduction
Juvenile idiopathic arthritis (JIA) refers to a collection of
chronic arthropathies in children with an onset before the age
of 16 and a yet unknown etiology, but with a multifactorial
inﬂuence linked to immune, infectious and genetic factors.1
The literature shows higher disease prevalence in sib-
lings, as well as in ﬁrst-degree relatives with other rheumatic
diseases, thus demonstrating the magnitude of genetic contri-
bution to disease susceptibility.2 Several genetic studies have
focused the understanding of major histocompatibility com-
plex (MHC) polymorphism contribution to JIA development
susceptibility. The results of these studies demonstrate asso-
ciations between JIA and genes encoding HLA and non-HLA.3
However, identifying genetic factors involved in JIA pathogen-
esis has been difﬁcult for several reasons, including a low
prevalence of familial cases and a lack of population stud-
ies estimating their risk of recurrence. Thus, few studies have
been conducted and they are often based on a low number of
cases.4




NSF, an 11 years and 8 months old boy, presented with prox-
imal interphalangeal joints (PIP) of the ﬁngers, knee and
ankle polyarthritis associated with an intermittent fever since
8 months of age. On physical examination, he had bilat-
eral 4th ﬁnger PIP, knee, and ankle synovial thickening and
swelling with preserved range of movement. Antinuclear anti-
bodies (ANA) and rheumatoid factor (RF) were negative. The
patient failed to adhere to treatment for socioeconomic rea-
sons and was lost to follow up, but returned to the clinic
with a clinically active disease 9 years later and was then
accompanied by a younger brother, JPSF, a patient aged 5
years and 10 months with intermittent fever and arthri-
tis of metatarsophalangeal, knee, and ankle joints since 9
months of age. Claudication, wrist and knee synovial thick-
ening, bilateral knee arthritis, and a 5th-ﬁnger boutonniere
deformity were noted on physical examination. ANA and RF
were negative. After ruling out infectious diseases, malignan-
cies, and other systemic autoimmune diseases, the diagnosis
of polyarticular JIA (ILAR) was made for both brothers. They
are currently taking naproxen, methotrexate, and etanercept
(Fig. 1).
Second  report
IJS, an 8 year old boy, presented with a history of daily fever
(100.4–102.2 ◦F), evanescent skin rash, and additive polyarthri-
tis involving the wrists, elbows, knees, ankles, and proximal
interphalangeal joints since 11 months of age. On physi-
cal examination, hepatosplenomegaly, bilateral arthritis of
the knee, ankle, distal and proximal interphalangeal joints
and a nodule in the 3rd left PIP were noted. ANA and RFwere negative, and infections, malignancies and other sys-
temic autoimmune diseases were ruled out, thus leading to
a diagnosis of systemic JIA (ILAR). The treatment started with
methotrexate, naproxen, prednisolone, folic acid, and etan-
ercept with improvement of the fever, rash, morning stiffness
and articular manifestations. Three years later than the above-
mentioned diagnosis, his younger brother aged 5 years was
seen with a complaint of generalized joint pain for 5 months
associated with right wrist and knee swelling and high evening
fever with an onset two months earlier than joint features.
He had anorexia and weight loss. Hepatomegaly, right wrist
and knee swelling with local heat and pain on active and pas-
sive movement  were noted on physical examination. ANA and
RF were negative. Following the exclusion of other diseases,
the diagnosis of a systemic JIA was made and treatment with
indomethacin, methotrexate, and folic acid was initiated. He
showed good clinical and laboratory response to treatment.
They evolved to polyarticular and pauciarticular JIA, respec-
tively (Fig. 2).
Discussion
Despite genetic studies not being performed in those patients
described, evidence suggests that JIA is a complex disorder
inﬂuenced by multiple genetic and environmental factors.
JIA prevalence among individuals having siblings affected by
the disease is 15- to 30-fold higher than in general popu-
lation and the risk of recurrence among siblings supports
the genetic contribution to the disease. In addition, stud-
ies demonstrate pairs of siblings affected by JIA have similar
human leukocyte antigens (HLA) and clinical features, with
a concordance rate in monozygotic twins of 25%, thus sug-
gesting a 250-fold higher prevalence than in the general
population.4
There are literature reports on the effects of genetics
on pairs of affected siblings or, less frequently, on twins.
Baum et al. ﬁrstly described dizygotic twins concurrently
having JIA with a conﬁrmed degree of genome identity.
r e v b r a s r e u m a t o l . 2
Fig. 2 – Siblings aged 8 and 5 years (from left to right) with




























9. Moroldo MB, Chaudhari M, Shear E, Thompson SD, Glass DN,hereafter, other studies reported JIA in pairs of twins and
 number of them highlighted the disease onset within
 shorter time in twins than in other pairs of affected
iblings.5 Studies have further shown the same disease
nset and course subtype among siblings, as well as dif-
erent onset patterns, but a similar subsequent course,
mphasizing the inﬂuence and complexity of genetic effects
n JIA; however, the implicit mechanisms could not be
xplained.5,6
In a review study by Prahalad et al., the genetic inﬂuence
n JIA development is pointed out either within or out of HLA
egion.7
Säilä et al. studied patients from multiplex families of JIA
nd observed that the only signiﬁcant difference between
amilial and sporadic cases was an earlier onset of the dis-
ase in familial cases, with no essential difference in the
isease clinical features being seen between patients from
oth groups.8
Maroldo et al. investigated clinical phenotypes and demo-
raphic characteristics in 183 pairs of siblings affected by JIA to
etermine whether differences between clinical phenotypes
n the familial disease cohort compared with patients in the
poradic disease cohort existed. The results conﬁrmed the
onclusions from other studies showing a high concordance
ate for the disease onset type between pairs of siblings, except
or the subgroup of patients with systemic disease.9 Regarding
he current study, there was a concordance for the onset type
nly in the ﬁrst case report.
A fact that stands out in the current reports is the disease
nset at early ages. Al-Mayouf et al., by aiming to compare 0 1 5;5  5(1):75–78 77
patients with familial JIA versus sporadic JIA regarding clinical
and laboratory variables, observed results that were similar to
previous results regarding age of onset: patients with familial
JIA were signiﬁcantly younger at the disease onset and were
diagnosed earlier than patients in the sporadic group. How-
ever, the high degree of concordance regarding the onset type
seen in that group of cases was not consistent with previous
reports. The fact that data were collected from a hospital that
is the main tertiary center in the country, which could repre-
sent a cohort of patients with more  severe JIA cases, would be
a reasonable explanation for the results.10
Recently, Prahalad et al. performed an analysis of the
largest available database and found that siblings and ﬁrst-
degree cousins of subjects with JIA have a higher risk to
develop the disease. The relative risks (RRs) for each class of
kinship were calculated through conditional logistic regres-
sion: RR in siblings and ﬁrst-degree cousins was elevated
compared with controls; the same fact did not occur with
second-degree cousins.11
In summary, genetic involvement in JIA pathogenesis is
clear; however, the ability to list the genes involved and under-
stand the contribution of gene products to the pathogenesis
will depend on large-scale well planned studies, as well as the
understanding of environmental contribution to the disease
triggering and perpetuation.
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